WO2016133134A1 - 有機化合物又は微生物の製造システム及び製造方法 - Google Patents
有機化合物又は微生物の製造システム及び製造方法 Download PDFInfo
- Publication number
- WO2016133134A1 WO2016133134A1 PCT/JP2016/054611 JP2016054611W WO2016133134A1 WO 2016133134 A1 WO2016133134 A1 WO 2016133134A1 JP 2016054611 W JP2016054611 W JP 2016054611W WO 2016133134 A1 WO2016133134 A1 WO 2016133134A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ammonia
- gas
- nitrogen
- containing gas
- synthesizer
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 156
- 150000002894 organic compounds Chemical class 0.000 title claims abstract description 68
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 669
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 302
- 239000007789 gas Substances 0.000 claims abstract description 174
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 166
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 80
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 65
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 58
- 239000001257 hydrogen Substances 0.000 claims abstract description 56
- 239000003054 catalyst Substances 0.000 claims abstract description 50
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 229910052707 ruthenium Inorganic materials 0.000 claims abstract description 37
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000012258 culturing Methods 0.000 claims abstract description 14
- 244000005700 microbiome Species 0.000 claims description 74
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 63
- 238000000034 method Methods 0.000 claims description 62
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 58
- 238000006243 chemical reaction Methods 0.000 claims description 47
- 238000004064 recycling Methods 0.000 claims description 23
- 241000894006 Bacteria Species 0.000 claims description 21
- 238000001035 drying Methods 0.000 claims description 15
- 239000003002 pH adjusting agent Substances 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 9
- 150000004676 glycans Chemical class 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- 229940088710 antibiotic agent Drugs 0.000 claims description 8
- 230000002194 synthesizing effect Effects 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 8
- 230000018044 dehydration Effects 0.000 claims description 7
- 238000006297 dehydration reaction Methods 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 7
- 241000233866 Fungi Species 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 6
- 235000005985 organic acids Nutrition 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 43
- 230000015572 biosynthetic process Effects 0.000 abstract description 40
- 238000000855 fermentation Methods 0.000 abstract description 20
- 230000004151 fermentation Effects 0.000 abstract description 20
- 230000000813 microbial effect Effects 0.000 abstract description 15
- 239000002609 medium Substances 0.000 description 26
- 238000000926 separation method Methods 0.000 description 26
- 239000012528 membrane Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 21
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 21
- 235000011130 ammonium sulphate Nutrition 0.000 description 21
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 21
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 20
- -1 diene compounds Chemical class 0.000 description 20
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 17
- 238000001816 cooling Methods 0.000 description 16
- 238000001179 sorption measurement Methods 0.000 description 16
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000395 magnesium oxide Substances 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
- 241000186226 Corynebacterium glutamicum Species 0.000 description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 8
- 241000186660 Lactobacillus Species 0.000 description 8
- 241000187747 Streptomyces Species 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229940039696 lactobacillus Drugs 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 239000004472 Lysine Substances 0.000 description 7
- 229960002989 glutamic acid Drugs 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 208000005156 Dehydration Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000589516 Pseudomonas Species 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229910001873 dinitrogen Inorganic materials 0.000 description 6
- 239000001963 growth medium Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 235000019766 L-Lysine Nutrition 0.000 description 5
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000003463 adsorbent Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 150000003863 ammonium salts Chemical class 0.000 description 5
- 239000004202 carbamide Substances 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 150000002430 hydrocarbons Chemical class 0.000 description 5
- 229910017604 nitric acid Inorganic materials 0.000 description 5
- 239000013076 target substance Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000012736 aqueous medium Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 238000012136 culture method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003230 hygroscopic agent Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000194019 Streptococcus mutans Species 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 229910052792 caesium Inorganic materials 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- 239000003120 macrolide antibiotic agent Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000002823 nitrates Chemical class 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241001465318 Aspergillus terreus Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 238000009623 Bosch process Methods 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 241000588914 Enterobacter Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 241000186712 Lactobacillus animalis Species 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 241000235395 Mucor Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 241000520272 Pantoea Species 0.000 description 2
- 241000588696 Pantoea ananatis Species 0.000 description 2
- 241000372441 Pelomonas Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 241000235346 Schizosaccharomyces Species 0.000 description 2
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000194048 Streptococcus equi Species 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- 241000235013 Yarrowia Species 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 2
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003245 coal Substances 0.000 description 2
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 239000001573 invertase Substances 0.000 description 2
- 235000011073 invertase Nutrition 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000002923 metal particle Substances 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 239000003345 natural gas Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000011941 photocatalyst Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229960002965 pravastatin Drugs 0.000 description 2
- TUZYXOIXSAXUGO-PZAWKZKUSA-M pravastatin(1-) Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-M 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 238000000629 steam reforming Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000193401 Clostridium acetobutylicum Species 0.000 description 1
- VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101100398755 Escherichia coli (strain K12) ldcC gene Proteins 0.000 description 1
- 101100024384 Escherichia coli (strain K12) mscS gene Proteins 0.000 description 1
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241000146406 Fusarium heterosporum Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 238000009620 Haber process Methods 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 108010048581 Lysine decarboxylase Proteins 0.000 description 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
- 241000498617 Mucor javanicus Species 0.000 description 1
- 101100276041 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) ctpD gene Proteins 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 241000187433 Streptomyces clavuligerus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 229910052810 boron oxide Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 101150008667 cadA gene Proteins 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Natural products O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- PMHQVHHXPFUNSP-UHFFFAOYSA-M copper(1+);methylsulfanylmethane;bromide Chemical compound Br[Cu].CSC PMHQVHHXPFUNSP-UHFFFAOYSA-M 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 150000002313 glycerolipids Chemical class 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 229910000449 hafnium oxide Inorganic materials 0.000 description 1
- WIHZLLGSGQNAGK-UHFFFAOYSA-N hafnium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Hf+4] WIHZLLGSGQNAGK-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- 229960004844 lovastatin Drugs 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 description 1
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- KJOMYNHMBRNCNY-UHFFFAOYSA-N pentane-1,1-diamine Chemical compound CCCCC(N)N KJOMYNHMBRNCNY-UHFFFAOYSA-N 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229940081969 saccharomyces cerevisiae Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical group CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/02—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the alkali- or alkaline earth metals or beryllium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/02—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the alkali- or alkaline earth metals or beryllium
- B01J23/04—Alkali metals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/46—Ruthenium, rhodium, osmium or iridium
- B01J23/462—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
- B01J23/56—Platinum group metals
- B01J23/58—Platinum group metals with alkali- or alkaline earth metals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J35/00—Catalysts, in general, characterised by their form or physical properties
- B01J35/19—Catalysts containing parts with different compositions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
- B01J37/02—Impregnation, coating or precipitation
- B01J37/0215—Coating
- B01J37/0221—Coating of particles
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
- C01C1/00—Ammonia; Compounds thereof
- C01C1/02—Preparation, purification or separation of ammonia
- C01C1/04—Preparation of ammonia by synthesis in the gas phase
- C01C1/0405—Preparation of ammonia by synthesis in the gas phase from N2 and H2 in presence of a catalyst
- C01C1/0411—Preparation of ammonia by synthesis in the gas phase from N2 and H2 in presence of a catalyst characterised by the catalyst
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
- C01C1/00—Ammonia; Compounds thereof
- C01C1/02—Preparation, purification or separation of ammonia
- C01C1/04—Preparation of ammonia by synthesis in the gas phase
- C01C1/0405—Preparation of ammonia by synthesis in the gas phase from N2 and H2 in presence of a catalyst
- C01C1/0417—Preparation of ammonia by synthesis in the gas phase from N2 and H2 in presence of a catalyst characterised by the synthesis reactor, e.g. arrangement of catalyst beds and heat exchangers in the reactor
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
- C01C1/00—Ammonia; Compounds thereof
- C01C1/02—Preparation, purification or separation of ammonia
- C01C1/04—Preparation of ammonia by synthesis in the gas phase
- C01C1/0405—Preparation of ammonia by synthesis in the gas phase from N2 and H2 in presence of a catalyst
- C01C1/0458—Separation of NH3
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
- C01C1/00—Ammonia; Compounds thereof
- C01C1/02—Preparation, purification or separation of ammonia
- C01C1/04—Preparation of ammonia by synthesis in the gas phase
- C01C1/0405—Preparation of ammonia by synthesis in the gas phase from N2 and H2 in presence of a catalyst
- C01C1/0476—Purge gas treatment, e.g. for removal of inert gases or recovery of H2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/58—Reaction vessels connected in series or in parallel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M43/00—Combinations of bioreactors or fermenters with other apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2203/00—Integrated processes for the production of hydrogen or synthesis gas
- C01B2203/02—Processes for making hydrogen or synthesis gas
- C01B2203/0205—Processes for making hydrogen or synthesis gas containing a reforming step
- C01B2203/0227—Processes for making hydrogen or synthesis gas containing a reforming step containing a catalytic reforming step
- C01B2203/0233—Processes for making hydrogen or synthesis gas containing a reforming step containing a catalytic reforming step the reforming step being a steam reforming step
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2203/00—Integrated processes for the production of hydrogen or synthesis gas
- C01B2203/02—Processes for making hydrogen or synthesis gas
- C01B2203/025—Processes for making hydrogen or synthesis gas containing a partial oxidation step
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2203/00—Integrated processes for the production of hydrogen or synthesis gas
- C01B2203/02—Processes for making hydrogen or synthesis gas
- C01B2203/0283—Processes for making hydrogen or synthesis gas containing a CO-shift step, i.e. a water gas shift step
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2203/00—Integrated processes for the production of hydrogen or synthesis gas
- C01B2203/04—Integrated processes for the production of hydrogen or synthesis gas containing a purification step for the hydrogen or the synthesis gas
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B2203/00—Integrated processes for the production of hydrogen or synthesis gas
- C01B2203/04—Integrated processes for the production of hydrogen or synthesis gas containing a purification step for the hydrogen or the synthesis gas
- C01B2203/0465—Composition of the impurity
- C01B2203/0475—Composition of the impurity the impurity being carbon dioxide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Definitions
- the present invention relates to an organic compound or microorganism production system and production method.
- a technique for producing an organic compound by culturing a microorganism capable of producing an organic compound is widely known.
- there are many documents relating to techniques for producing amino acids by culturing bacteria having amino acid-producing ability for example, Patent Documents 1 and 2 and Non-Patent Document 1). It has been produced by the amino acid fermentation method.
- techniques for producing various organic compounds such as polysaccharides, proteins, antibiotics, alcohols, acrylamides and diene compounds by microbial fermentation are known, and research and development are ongoing.
- Non-patent Document 2 ammonia and nitrogen-containing compounds derived from ammonia (for example, ammonium salts, urea, nitric acid, nitrates, etc.) are generally used as nitrogen sources and pH adjusters (Non-patent Document 2).
- Ammonia is mainly produced by a large-scale production process by the Haber-Bosch process.
- a source gas containing hydrogen and nitrogen is added to 400
- Ammonia is synthesized by reacting under high temperature and high pressure conditions of 20 ° C. to 600 ° C. and 20 MPa to 100 MPa.
- An object of the present invention is to provide a novel production system and production method that do not involve (or can minimize) the transport of liquid ammonia during the production of an organic compound by microbial fermentation.
- an object of the present invention is to provide a novel production system and production method that do not involve (or can minimize) the transport of liquid ammonia during the production of microorganisms.
- the present invention includes the following contents.
- An ammonia synthesizer for synthesizing an ammonia-containing gas by reacting a source gas containing hydrogen and nitrogen in the presence of a supported ruthenium catalyst;
- An organic compound or microorganism production system comprising: [2] The production system according to [1], wherein the raw material gas is reacted under the conditions of a reaction temperature of 530 ° C. or lower and a reaction pressure of 30 MPa or lower in an ammonia synthesizer.
- Ammonia water is produced using ammonia derived from an ammonia-containing gas obtained by an ammonia synthesizer, and microorganisms capable of producing organic compounds are cultured using the obtained ammonia water.
- ammonia derived from the ammonia-containing gas obtained by the ammonia synthesizer ammonia water is produced, ammonia gas is recovered from the obtained ammonia water, and organic compounds are produced using the recovered ammonia gas.
- the production system according to any one of [1] to [5], wherein microorganisms having the ability are cultured.
- a method for producing an organic compound or microorganism comprising a step of culturing a microorganism capable of producing a compound.
- Ammonia water is produced using ammonia derived from the ammonia-containing gas obtained in the step (A), and a microorganism having an ability to produce an organic compound is produced using the obtained ammonia water in the step (B).
- Ammonia water is produced using ammonia derived from the ammonia-containing gas obtained in step (A), ammonia gas is recovered from the obtained ammonia water, and the recovered ammonia gas is recovered in step (B).
- FIG. 1 is a schematic diagram (1) showing a manufacturing system according to an embodiment of the present invention.
- FIG. 2 is a schematic diagram (2) showing the manufacturing system in one embodiment of the present invention.
- FIG. 3 is a schematic diagram (3) showing the manufacturing system in one embodiment of the present invention.
- FIG. 4 is a schematic diagram (4) showing the manufacturing system in one embodiment of the present invention.
- the present invention provides a novel production system for organic compounds or microorganisms.
- ammonia synthesis by large-scale production processes is based on the premise that the synthesized ammonia is liquefied and stored, and transported as liquid ammonia to the ammonia consumption area. Cost tended to increase.
- ammonia used as a nitrogen source or a pH adjuster necessary for microbial fermentation is produced (that is, on-site production) in a place where the microbial fermentation is performed.
- an organic compound or a microorganism can be produced by microbial fermentation without involving storage / transport of liquid ammonia.
- the organic compound or microorganism production system of the present invention comprises: An ammonia synthesizer for synthesizing an ammonia-containing gas by reacting a source gas containing hydrogen and nitrogen in the presence of a supported ruthenium catalyst; A culture apparatus for culturing microorganisms capable of producing organic compounds using ammonia derived from an ammonia-containing gas obtained by an ammonia synthesizer; including.
- the ammonia synthesizer synthesizes the ammonia-containing gas by reacting the raw material gas containing hydrogen and nitrogen in the presence of the supported ruthenium catalyst.
- ammonia is currently produced mainly by the Harbor Bosch process.
- ammonia is synthesized by reacting a source gas containing hydrogen and nitrogen under high temperature and high pressure conditions of 400 ° C. to 600 ° C. and 20 MPa to 100 MPa using a double promoter iron catalyst.
- a supported ruthenium catalyst is used as the ammonia synthesis catalyst.
- the supported ruthenium catalyst can exhibit high ammonia synthesis activity even under low pressure conditions, as compared with the double promoted iron catalyst used in the Harbor Bosch process.
- the support is not particularly limited as long as it can support ruthenium and does not inhibit the catalytic ability of ruthenium in ammonia synthesis, and a known support may be used.
- the carrier include silicon oxide (silica), zinc oxide, aluminum oxide (alumina), magnesium oxide (magnesia), indium oxide, calcium oxide, zirconium oxide (zirconia), titanium oxide (titania), boron oxide, and hafnium oxide. Oxides such as barium oxide, cerium oxide (ceria) and zeolite; nitrides such as silicon nitride, aluminum nitride, boron nitride and magnesium nitride; activated carbon.
- carrier may be used individually by 1 type and may be used in combination of 2 or more type.
- the supported ruthenium catalyst may contain one or more elements selected from the group consisting of alkali metals, alkaline earth metals, and rare earth elements as a promoter component.
- the supported amount of ruthenium in the supported ruthenium catalyst is preferably 0.01 wt% or more, more preferably 0.02 wt% or more, and further preferably 0.03 wt% or more when the support is 100 wt%. 0.05 wt% or more, 0.1 wt% or more, 0.3 wt% or more, 0.5 wt% or more, or 1 wt% or more.
- the upper limit of the amount of ruthenium supported is preferably 30 wt% or less, more preferably 20 wt% or less, and even more preferably from the viewpoint of maintaining the intended ammonia synthesis activity by suppressing sintering of ruthenium particles during the ammonia synthesis reaction. Is 15 wt% or less, or 10 wt% or less.
- the amount of the promoter component supported on the supported ruthenium catalyst is not particularly limited, but from the viewpoint of ammonia synthesis activity, when ruthenium is 100 wt%, preferably 0.01 wt% to 1000 wt%, More preferably, it is 1 wt% to 800 wt%.
- the specific surface area of the supported ruthenium catalyst is not particularly limited, but is preferably 0.1 m 2 / g to 1000 m 2 / g, more preferably 0.5 m 2 / g to 800 m 2 / g.
- the specific surface area of the supported ruthenium catalyst can be measured, for example, by the BET adsorption method.
- the method for preparing the supported ruthenium catalyst is not particularly limited, and an appropriate method may be selected from known methods according to the type of the carrier. For example, an impregnation method, a sol-gel method, a CVD method, a sputtering method, and the like can be given.
- the ammonia synthesizer is not particularly limited as long as it can synthesize an ammonia-containing gas by reacting a source gas containing hydrogen and nitrogen in the presence of the supported ruthenium catalyst, for example, hydrogen and nitrogen.
- combines ammonia containing gas by reacting raw material gas in presence of the said catalyst, and the exit of produced
- the reaction temperature is preferably 600 ° C. or lower, more preferably 550 ° C. or lower, further preferably 530 ° C. or lower, 500 ° C. or lower, 450 ° C. or lower, or 400 ° C. or lower from the viewpoint of facilitating ammonia synthesis in the ammonia consuming area. is there.
- the lower limit of the reaction temperature is preferably 100 ° C. or higher, more preferably 150 ° C. or higher, further preferably 200 ° C. or higher, 250 ° C. or higher, or 300 ° C. or higher, from the viewpoint of ammonia synthesis activity.
- the reaction pressure is preferably 30 MPa or less, more preferably 25 MPa or less, and even more preferably 20 MPa or less from the viewpoint of facilitating ammonia synthesis in an ammonia consuming area.
- excellent ammonia synthesis activity can be achieved even when the reaction pressure is lower.
- the reaction pressure may be 15 MPa or less, 10 MPa or less, 5 MPa or less, 4 MPa or less, 3 MPa or less, 2 MPa or less, or 1 MPa or less.
- the lower limit of the reaction pressure is preferably 10 kPa or more, more preferably 50 kPa or more, and still more preferably 100 kPa or more, from the viewpoint of the ammonia concentration at the outlet of the ammonia synthesizer that is governed by chemical equilibrium in a preferred embodiment.
- the reaction pressure is a gauge pressure (the same applies hereinafter).
- the reaction form may be any of a batch reaction form, a closed circulation reaction form, and a circulation reaction form, but from a practical viewpoint, a circulation reaction form is preferred.
- the internal heat exchange type that aims to maintain a large ammonia synthesis reaction rate by suppressing the temperature rise of the catalyst layer due to the reaction and raising the equilibrium ammonia concentration, or the raw material gas is divided and supplied in the fluid flow direction
- a known reactor structure such as a quencher type can be adopted.
- the supported ruthenium catalyst may be used alone or in combination of two or more.
- a supported ruthenium catalyst and another ammonia synthesis catalyst may be used in combination of two or more.
- two or more types of catalysts may be mixed and used depending on the reaction mode, and the catalysts are stacked and used so as to form a separate layer for each type.
- the reaction tubes may be used in combination after the catalyst is filled in separate reaction tubes so that different types of reaction tubes are filled.
- the water content in the raw material gas is preferably 100 ppm by volume or less, more preferably 50 ppm by volume or less.
- the lower limit of the water content is preferably as low as possible, and may be 0 ppm by volume.
- the molar ratio of hydrogen to nitrogen in the source gas is preferably 1/2 to 5/1, more preferably 1/2 to 3/1, still more preferably 1/2 to 2/1, More preferably, it is 4/5 to 6/5.
- Hydrogen in the raw material gas used for ammonia synthesis is a well-known method such as 1) hydrocarbon (eg, coal, petroleum, natural gas, biomass), steam reforming reaction, partial oxidation reaction, or a combination thereof. Preparation by a method of performing a CO shift reaction and de-CO 2 treatment after conversion to a gas containing CO and H 2 , 2) a method of electrolyzing water, 3) a method of decomposing water using a photocatalyst Can do.
- hydrogen may be supplied from a hydrogen cylinder (including a hydrogen cylinder), a hydrogen tank (including a mobile tank such as a hydrogen self-loader, and so on).
- Nitrogen in the raw material gas used for ammonia synthesis may be prepared by separating nitrogen from air using a nitrogen separation membrane or a cryogenic separation method. Or when preparing hydrogen using the partial oxidation reaction of a hydrocarbon, you may utilize the nitrogen in the air used as an oxygen source. Alternatively, nitrogen may be supplied from a nitrogen cylinder (including a nitrogen cylinder), a nitrogen tank (including a mobile tank such as a nitrogen self-loader, and the same).
- a raw material gas containing hydrogen and nitrogen can be prepared using a process that can be advantageously carried out in an ammonia consumption area.
- the ammonia concentration in the ammonia-containing gas synthesized in the ammonia synthesizer is preferably 0.5% by volume or more, more preferably 2% by volume or more, further preferably 4% by volume or more, 6% by volume. % Or more, 8 volume% or more, or 10 volume% or more.
- the ammonia-containing gas synthesized in the ammonia synthesizer mainly contains unreacted hydrogen and unreacted nitrogen in addition to ammonia.
- the ammonia synthesis capacity (ammonia-ton / day) of the ammonia synthesizer varies depending on the amount of ammonia used in the culture apparatus, but is preferably 300 tons / day, more preferably 200 tons / day or less. More preferably, it is 100 tons / day or less, 80 tons / day or less, 60 tons / day or less, or 50 tons / day or less.
- the lower limit of the ammonia synthesis capacity is not particularly limited, but can usually be 0.1 ton / day or more, 1 ton / day or more, 2 ton / day or more, and the like.
- microorganisms capable of producing organic compounds are cultured using ammonia derived from an ammonia-containing gas obtained by an ammonia synthesizer.
- ammonia is used as a nitrogen source or a pH adjuster.
- the ammonia-containing gas obtained in the ammonia synthesizer may be supplied directly to the culture apparatus after cooling 1) depending on the specific specifications of the culture apparatus 2) Concentrated and concentrated ammonia gas or liquid ammonia ( Alternatively, it may be supplied to the culture apparatus as ammonia water) if necessary, or 3) or ammonia gas may be recovered from the obtained ammonia water, and the recovered ammonia gas may be supplied to the culture apparatus.
- the expression that the ammonia-derived gas “derived” obtained by the ammonia synthesizer is used is used.
- Ammonia may also be supplied to the culture apparatus after being converted into an ammonia-derived nitrogen-containing compound such as ammonium salts such as ammonium sulfate, nitric acid, and nitrates.
- ammonia is used as a source of nitrogen source or pH adjuster.
- Such an embodiment is also encompassed in “use ammonia as a nitrogen source or pH adjuster” in the present invention.
- the production system of the present invention further includes a cooler for cooling the ammonia-containing gas obtained by the ammonia synthesizer.
- the cooler is not particularly limited as long as the ammonia-containing gas can be cooled to a predetermined temperature, and a known cooler (for example, a coil-type heat exchanger, a shell-and-tube heat exchanger, or the like) may be used.
- the cooled ammonia-containing gas may be supplied to the culture apparatus as it is, or may be supplied to the culture apparatus after being stored in a storage tank.
- the production system of the present invention further includes an ammonia concentrator that concentrates ammonia in the ammonia-containing gas obtained by the ammonia synthesizer.
- the ammonia concentrating device is not particularly limited as long as ammonia in the ammonia-containing gas can be concentrated, and a known concentrating device may be used. Examples of the ammonia concentrating device include a pressurized cooling device, a gas separation membrane device, and a pressure swing adsorption (PSA) device.
- PSA pressure swing adsorption
- the pressure cooling conditions are set so that ammonia in the ammonia-containing gas is liquefied.
- the pressure during pressure cooling varies depending on the reaction pressure in the reaction part of the ammonia synthesizer and the temperature during pressure cooling, but is preferably 10 kPa or more, more preferably 50 kPa or more, further preferably 100 kPa or more, 0.2 MPa or more. 0.3 MPa or more, 0.4 MPa or more, or 0.5 MPa or more.
- the temperature during pressure cooling varies depending on the pressure during pressure cooling, but is preferably 50 ° C. or less, more preferably 40 ° C. or less, still more preferably 30 ° C.
- the lower limit of the temperature is not particularly limited, but can usually be ⁇ 35 ° C. or higher, ⁇ 30 ° C. or higher, and the like.
- the pressure cooling device is not particularly limited as long as the ammonia-containing gas obtained by the ammonia synthesis device can be pressure-cooled under the above conditions, and a known pressure cooling device may be used. Liquid ammonia obtained by pressurizing and cooling the ammonia-containing gas may be supplied to the culture apparatus as it is, or may be supplied to the culture apparatus after being stored in a storage tank.
- a gas separation membrane device When a gas separation membrane device is used as the ammonia concentrator, it is preferable to use a hydrogen gas separation membrane, a nitrogen gas separation membrane, or a combination thereof.
- the ammonia-containing gas obtained by the ammonia synthesizer mainly contains ammonia, unreacted hydrogen, and unreacted nitrogen, and at least one of unreacted hydrogen and unreacted nitrogen is separated by a gas separation membrane. Thus, ammonia can be concentrated.
- the hydrogen gas separation membrane and the nitrogen gas separation membrane are not particularly limited as long as they can separate unreacted hydrogen and nitrogen in the ammonia-containing gas obtained by the ammonia synthesizer.
- Known hydrogen gas separation membranes and nitrogen gas separations A membrane may be used.
- an ammonia gas separation membrane that can selectively separate ammonia in the ammonia-containing gas may be used.
- concentration of ammonia using the gas separation membrane device conditions such as temperature and pressure may be determined according to the type of the gas separation membrane.
- the pressure during gas separation is preferably 10 kPa or more, more preferably 50 kPa or more, still more preferably 100 kPa or more, 0.2 MPa or more, 0.3 MPa or more, 0.4 MPa or more, or 0.5 MPa. That's it.
- the upper limit of the gas pressure (crude gas side) is not particularly limited, but is usually equal to or lower than the reaction pressure in the reaction part of the ammonia synthesizer.
- the concentrated ammonia gas obtained by the gas separation membrane device may be supplied to the culture device as it is, or may be supplied to the culture device after being stored in a storage tank.
- a pressure swing adsorption (PSA) device may be used as the ammonia concentrator.
- the PSA system uses an adsorbent that selectively adsorbs ammonia in the ammonia-containing gas and controls ammonia adsorption / desorption by pressure fluctuations to separate ammonia from other gases (concentrate ammonia).
- the PSA device is not particularly limited as long as ammonia in the ammonia-containing gas can be concentrated, and a known PSA device may be used.
- the ammonia in the ammonia-containing gas may be concentrated using a PSA device described in Japanese Patent No. 2634015.
- the pressure (P ad ) for adsorbing ammonia on the adsorbent and the pressure (P de ) for desorbing ammonia from the adsorbent satisfy P ad > P de .
- the P ad and P de preferably satisfy P ad ⁇ P de ⁇ 10 kPa, more preferably P ad ⁇ P de ⁇ 50 kPa, It is further preferable to satisfy P ad ⁇ P de ⁇ 100 kPa, and even more preferable to satisfy P ad ⁇ P de ⁇ 0.2 MPa, P ad ⁇ P de ⁇ 0.3 MPa, P ad ⁇ P de ⁇ 0.4 MPa Or P ad ⁇ P de ⁇ 0.5 MPa is particularly preferable.
- the upper limit of the difference between P ad and P de is usually equal to or lower than the reaction pressure in the reaction section of the ammonia synthesizer.
- P ad is not particularly limited as long as the above P ad > P de is satisfied, and may be determined according to the adsorption capacity of the adsorbent to be used, but is usually equal to or lower than the reaction pressure in the reaction section of the ammonia synthesizer.
- P de is not particularly limited as long as P ad > P de is satisfied, and may be determined according to the desorption ability of the adsorbent to be used, but is usually 1 MPa or less, preferably 0.5 MPa or less, 0. 2 MPa or less, 100 kPa or less, 50 kPa or less, 10 kPa or less, or 0 kPa or less.
- the temperature at the time of gas separation may be determined according to the specific specification of the PSA apparatus.
- a PSA device having two or more adsorption towers is suitable.
- a PSA apparatus equipped with two adsorption towers a first adsorption tower and a second adsorption tower
- the ammonia adsorption process is performed in the first adsorption tower
- the ammonia adsorption is performed in the second adsorption tower.
- the desorption step is performed and the ammonia desorption step is performed in the first adsorption tower
- the operation is performed so that the ammonia adsorption step is performed in the second adsorption tower. It is possible to concentrate the ammonia.
- the concentrated ammonia gas obtained by the PSA apparatus may be supplied to the culture apparatus as it is, or may be supplied to the culture apparatus after being stored in a storage tank.
- the ammonia concentration in the concentrated ammonia gas obtained by the ammonia concentrator is preferably 10% by volume or more, more preferably 30% by volume or more, and even more preferably 50% by volume or more.
- the upper limit of the ammonia concentration is preferably as high as possible, and may be 100% by volume. Therefore, in the present invention, “concentration” of ammonia is a concept including isolating ammonia from an ammonia-containing gas.
- the ammonia-containing gas obtained by the ammonia synthesizing apparatus may be further purified using an ammonia purifying apparatus after the ammonia is concentrated by the ammonia concentrating apparatus.
- the ammonia-containing gas obtained by the ammonia synthesizer contains unreacted hydrogen and unreacted nitrogen.
- the production system of the present invention further includes a recycle device that recovers unreacted hydrogen and nitrogen downstream of the ammonia synthesizer and recycles the recovered gas upstream of the ammonia synthesizer.
- a recycling apparatus may be provided in the culture apparatus. Details of the recycling apparatus will be described later with reference to the drawings.
- ammonia-containing gas obtained by the ammonia synthesizer is concentrated and supplied to the culture apparatus as concentrated ammonia gas or liquid ammonia (or ammonia water as necessary), unreacted hydrogen in the ammonia concentrator And nitrogen can be selectively recovered, and a recycling device may be provided in the ammonia concentrator.
- the recycling device is not particularly limited as long as it can recover unreacted hydrogen and nitrogen, and the recovered gas containing hydrogen and nitrogen can be recycled to the upstream side of the ammonia synthesizer.
- a known recycling device is used. You can do it.
- the recycling device may include a recovered gas conduit and a pump for transferring the recovered gas.
- the recycling apparatus includes a dehydrating apparatus that removes moisture in the collected gas.
- the dehydration apparatus is not particularly limited as long as the water content in the recovered gas can be reduced to a value that does not adversely affect the catalytic performance of the supported ruthenium catalyst used in the present invention, and a known dehydration apparatus is used. It's okay. For example, a device that condenses and removes moisture by cooling the recovered gas can be used.
- the recycling apparatus may use a drying apparatus, and may include a drying apparatus in addition to or instead of the dehydrating apparatus.
- the drying device is not particularly limited as long as it has a function of further reducing the moisture content in the recovered gas, and a known drying device may be used.
- an apparatus that dehydrates the recovered gas by contacting it with a hygroscopic agent is not particularly limited.
- chemicals such as calcium chloride, diphosphorus pentoxide, and anhydrous copper sulfate are available.
- Physical hygroscopic agents physical hygroscopic agents such as silica gel, alumina gel and zeolite.
- the culture apparatus cultivates a microorganism having an ability to produce an organic compound using ammonia derived from the ammonia-containing gas obtained by the ammonia synthesizer.
- a technique for producing an organic compound by culturing a microorganism capable of producing an organic compound is widely known.
- the present invention can be widely applied to such a microbial fermentation technique.
- organic compounds produced in microbial fermentation include amino acids, organic acids, polysaccharides, proteins, antibiotics, and alcohols.
- amino acids include glycine, alanine, valine, leucine, isoleucine, serine, threonine, cysteine, cystine, methionine, phenylalanine, tyrosine, tryptophan, proline, hydroxyproline, asparagine, glutamine, aspartic acid, glutamic acid, lysine, histidine, Arginine is mentioned.
- Examples of the organic acid include acetic acid, lactic acid, pyruvic acid, succinic acid, malic acid, itaconic acid, citric acid, acrylic acid, propionic acid, and fumaric acid.
- Examples of the polysaccharide include xanthan, dextran, alginate, hyaluronic acid, curdlan, gellan, scleoglucan, and pullulan.
- proteins include hormones, lymphokines, interferons, and enzymes (amylase, glucoamylase, invertase, lactase, protease, lipase, etc.).
- Antibiotics include, for example, antibacterial agents ( ⁇ -lactams, macrolides, ansamycins, tetracyclines, chloramphenicol, peptide antibiotics, aminoglycosides, etc.), antifungal agents (polyoxin B, griseofulvin, polyene macrolides, etc.) , Anti-cancer drugs (daunomycin, adriamycin, dactinomycin, misramycin, bleomycin, etc.), protease / peptidase inhibitors (leupeptin, antipine, pepstatin, etc.), cholesterol biosynthesis inhibitors (compactin, lovastatin, pravastatin, etc.) Can be mentioned.
- antibacterial agents ⁇ -lactams, macrolides, ansamycins, tetracyclines, chloramphenicol, peptide antibiotics, aminoglycosides, etc.
- antifungal agents polyoxin B, griseofulvin
- Examples of the alcohol include ethanol, isopropanol, glycerin, propylene glycol, trimethylene glycol, 1-butanol, and sorbit.
- Examples of organic compounds produced in microbial fermentation also include acrylamide, diene compounds (such as isoprene), and pentanediamine.
- Microorganisms capable of producing organic compounds include 1) microorganisms that are inherently capable of producing organic compounds, and 2) organic compounds that are inherently not or substantially not capable of producing organic compounds. This includes both microorganisms that have been introduced by gene recombination and have acquired the ability to produce organic compounds. Regarding microorganisms having the ability to produce organic compounds, various microorganisms are known depending on the type of organic compound, and these known microorganisms may be widely used in the present invention. In addition, as long as ammonia can be used as a nitrogen source or a pH adjuster during culture, the present invention can be widely applied to microorganisms to be developed in the future.
- the microorganism is not particularly limited as long as it has the ability to produce organic compounds, but bacteria or fungi are preferred.
- bacteria include Escherichia bacteria, Pantoea bacteria, Corynebacterium bacteria, Enterobacter bacteria, Clostridium bacteria, and Bacillus bacteria. , Lactobacillus genus bacteria, Streptomyces genus bacteria, Streptococcus genus bacteria, Pseudomonas genus bacteria.
- the fungi include, for example, Saccharomyces, Schizosaccharomyces, Yarrowia, Trichoderma, Aspergillus, Aspergillus, and Aspergillus Examples include the genus Mucor.
- Examples of bacteria belonging to the genus Escherichia include Escherichia coli and the like.
- Pantoea bacteria include Pantoea ananatis and the like.
- Examples of bacteria belonging to the genus Corynebacterium include Corynebacterium glutamicum, Corynebacterium ammoniagenes, and the like.
- Examples of Enterobacter bacteria include, for example, Enterobacter aerogenes.
- Examples of bacteria belonging to the genus Clostridium include Clostridium acetobutylicum.
- Examples of bacteria belonging to the genus Bacillus include Bacillus subtilis and Bacillus amyloliquefaciens.
- Examples of bacteria belonging to the genus Lactobacillus include Lactobacillus yamanasiensis, Lactobacillus animalis, Lactobacillus bilgaris, and Lactobacillus bilgaris Lactobacillus.
- Examples of bacteria belonging to the genus Streptomyces include Streptomyces clavuligerus, Streptomyces venezuela, and Streptomyces pisteus c.
- Examples of the genus Streptococcus include Streptococcus equi, Streptococcus mutans, and the like.
- Examples of the genus Pseudomonas include, for example, Pseudomonas fluorescens, Pseudomonas aeruginosa, Pseudomonas pelomonas, Pseudomonas pelomonas, and Pseudomonas erodeu.
- Examples of the genus Saccharomyces include Saccharomyces cerevisiae.
- Examples of the genus Schizosaccharomyces include Schizosaccharomyces pombe.
- Examples of the genus Yarrowia include Yarrowia lipolytica.
- Examples of the genus Trichoderma include Trichoderma reesei.
- Examples of Aspergillus genus bacteria include Aspergillus terreus and Aspergillus oryzae.
- Examples of the genus Fusarium include Fusarium heterosporum and the like.
- Examples of the genus Mucor include Mucor javanicus and the like.
- microorganisms When producing amino acids in the production system of the present invention, examples of microorganisms that can be suitably used include the following.
- the target substance is L-lysine, Escherichia coli AJ11442 (NRRL B-12185, FERM BP-1543) (see US Pat. No. 4,346,170), Brevibacterium lactofermentum AJ3990 (ATCC 31269) ( U.S. Pat. No. 4,066,501), Lys producing bacterium WC196LC / pCABD2 (International Publication No. 2010/061890), and the like.
- WC196 ⁇ cadA ⁇ ldc is a strain constructed by disrupting the cadA and ldcC genes encoding lysine decarboxylase from the WC196 strain.
- WC196 ⁇ cadA ⁇ ldc / pCABD2 is a strain constructed by introducing plasmid pCABD2 (US Pat. No. 6,040,160) containing a lysine biosynthesis gene into WC196 ⁇ cadA ⁇ ldc.
- WC196 ⁇ cadA ⁇ ldc is named AJ110692, and on October 7, 2008, National Institute of Advanced Industrial Science and Technology, Patent Biological Depositary Center (now National Institute of Technology and Evaluation, Patent Biological Depositary Center, ZIP Code: 292-0818) , Address: 2-5-8, Kazusa Kamashishi, Kisarazu City, Chiba, Japan (Room 120). Deposited under the deposit number FERM BP-11027.
- Escherichia coli VKPM B-3996 (RIA 1867, VKPM B-3996) (see US Pat. No. 5,175,107), Corynebacterium acetoaside film AJ12318 (FERM BP-1172) (See U.S. Pat. No.
- L-lactic acid is Lactobacillus yamanasiensis, Lactobacillus animalis, Saccharomyces cerevisiae, etc.
- pyruvate is Escherichia coli, Pseudomonas fluorescens, etc.
- succinic acid is Escherichia. ⁇ Cori, Pantoea ananatis, etc.
- itaconic acid Aspergillus terreus, etc.
- citric acid Escherichia coli, etc. (for example, International Publication No. 2007/097260, JP 2010-187542 A) reference).
- microorganisms When producing a polysaccharide in the production system of the present invention, examples of microorganisms that can be suitably used include the following.
- the target substance is dextran, it is Lactobacillus hirugardi, Streptococcus mutans, etc.
- when it is alginate it is Pseudomonas aeruginosa, etc.
- when it is hyaluronic acid it is Streptococcus equi, Streptococcus mutans, etc.
- Pseudomonas erodea or the like (see, for example, JP 2011-116825 A and JP 2007-9092 A).
- microorganisms When producing proteins in the production system of the present invention, examples of microorganisms that can be suitably used include the following.
- the target substance is various hormones, interferon, Saccharomyces cerevisiae, etc., amylase, glucoamylase, protease, lipase, Bacillus subtilis, Aspergillus oryzae, etc., invertase, lactase, Saccharomyces cerevisiae, Aspergillus oryzae (see, for example, International Publication No. 2006/67511, Japanese Patent Application Laid-Open No. 2003-153696).
- microorganisms When producing antibiotics in the production system of the present invention, examples of microorganisms that can be suitably used include the following.
- the target substance is ⁇ -lactam such as penicillin, it is Pseudomonas putida, Streptomyces crabriggers, etc., and when it is a macrolide such as erythromycin or azithromycin, it is Streptomyces venezuela, etc., and daunomycin Is Streptomyces piusettius or the like
- pravastatin is Streptomyces club ligels or the like (for example, International Publication No. 96/10084, Japanese Patent Application Laid-Open No. 2002-53589, International Publication No. 2005/54265). , International Publication No. 2007/147827).
- microorganisms When producing alcohol in the production system of the present invention, examples of microorganisms that can be suitably used include the following.
- the target substance is ethanol
- Saccharomyces cerevisiae, Schizosaccharomyces pombe, Lactobacillus brevis and the like are used
- Trimethylene glycol is used, Escherichia coli and the like are used (see, for example, International Publication No. 2007/97260).
- the medium for culturing microorganisms preferably contains a carbon source and a nitrogen source for conversion to an organic compound.
- the carbon source include carbohydrates such as monosaccharides, disaccharides, oligosaccharides, and polysaccharides; invert sugar obtained by hydrolyzing sucrose; glycerol; carbon atoms such as methanol, formaldehyde, formate, carbon monoxide, and carbon dioxide Compound of number 1; oil such as corn oil, palm oil, soybean oil; acetate; animal oil; animal oil; fatty acid such as saturated fatty acid and unsaturated fatty acid; lipid; phospholipid; glycerolipid; monoglyceride, diglyceride, triglyceride, etc.
- Glycerin fatty acid esters polypeptides such as microbial proteins and plant proteins; renewable carbon sources such as hydrolyzed biomass carbon sources; yeast extracts; and combinations thereof.
- the nitrogen source include inorganic nitrogen sources such as ammonia, ammonium salts, nitric acid and nitrates; organic nitrogen sources such as urea, amino acids and proteins; and combinations thereof.
- a culture medium contains an inorganic ion and another organic trace component as needed in addition to a carbon source and a nitrogen source. Conventionally known arbitrary components may be used as such inorganic ions and other organic trace components.
- the medium may be a natural medium or a synthetic medium.
- Culture conditions are not particularly limited as long as the target organic compound can be produced, and standard microorganism culture conditions may be used.
- the culture temperature is preferably 20 ° C. to 37 ° C.
- the culture method a known method such as a batch culture method, a fed-batch culture method, or a continuous culture method may be used.
- the liquid depth (medium depth) in the culture apparatus may be appropriately determined according to the characteristics of the microorganism. For example, in aerobic culture, when it is necessary to keep the medium stationary for the growth of microorganisms, a culture apparatus (culture tank) with a small liquid depth may be used. When the amount of oxygen required is large, a deep culture apparatus that supplies air to the culture medium by directly ventilating air into a stirring tank or a bubble column may be used.
- the method for supplying ammonia to the culture device is not particularly limited, and may be supplied to the gas phase of the culture device or supplied to the medium according to the form of ammonia (ammonia gas, liquid ammonia, ammonia water). Good.
- ammonia is converted into an ammonia-derived nitrogen-containing compound (ammonium salt, urea, nitric acid, nitrate) and then supplied to the culture apparatus, it may be supplied into the medium.
- Supply of ammonia or the nitrogen-containing compound derived from ammonia can be carried out according to a known method.
- the amount of ammonia or ammonia-derived nitrogen-containing compound supplied to the culture apparatus may be determined according to the specific design of the culture apparatus including the type of microorganism having the ability to produce organic compounds.
- FIG. 1 shows a production system 1000 including a raw material gas production apparatus 101, an ammonia synthesis apparatus 102, an ammonia concentration apparatus 103 selected from a pressure cooling apparatus and a PSA apparatus, and a culture apparatus 203.
- the hydrogen gas raw material 1 and the air 2 are supplied to the raw material gas manufacturing apparatus 101.
- the hydrogen gas raw material 1 hydrocarbons (for example, coal, petroleum, natural gas, biomass) and water may be used according to the hydrogen production process in the raw material gas production apparatus 101.
- the hydrogen production process is as follows. 1) After converting hydrocarbons into gas containing CO and H 2 by steam reforming reaction, partial oxidation reaction, or a combination thereof, CO shift reaction, de-CO 2 2 ) A method of performing treatment, 2) a method of electrolyzing water, and 3) a method of decomposing water using a photocatalyst.
- nitrogen is also produced. Nitrogen may be prepared by separating nitrogen from air using a nitrogen separation membrane or a cryogenic separation method. Or when preparing hydrogen using the partial oxidation reaction of a hydrocarbon, you may utilize the nitrogen in the air used as an oxygen source.
- the raw material gas 3 containing hydrogen and nitrogen produced by the raw material gas production device 101 is supplied to the ammonia synthesis device 102.
- an ammonia-containing gas is synthesized by reacting a source gas containing hydrogen and nitrogen in the presence of a supported ruthenium catalyst.
- the synthesized ammonia-containing gas 4 is supplied to an ammonia concentrating device 103 selected from a pressurized cooling device and a PSA device.
- an ammonia concentrating device 103 selected from a pressurized cooling device and a PSA device.
- the ammonia concentrating device 103 is a pressure cooling device, liquid ammonia 6 is obtained.
- the ammonia concentrating device 103 is a PSA device, concentrated ammonia gas 6 is obtained.
- the obtained liquid ammonia or concentrated ammonia gas may be stored in a storage tank (not shown).
- the obtained liquid ammonia or concentrated ammonia gas 6 is supplied to the culture apparatus 203.
- An appropriate medium is introduced into the culture apparatus 203 according to the type of microorganism having the ability to produce organic compounds, and air 13 is supplied as necessary.
- ammonia 6 is used as a nitrogen source or a pH adjuster.
- the organic compound or microorganism 14 can be produced by culturing a microorganism capable of producing an organic compound.
- the manufacturing system 1000 shown in FIG. 1 recovers unreacted hydrogen and nitrogen separated by the ammonia concentrator 103 and recycles the recovered gas 5 upstream of the ammonia synthesizer 102 (not shown). Prepared).
- FIG. 2 shows a production system 1001 including a raw material gas production apparatus 101, an ammonia synthesis apparatus 102, gas separation membrane apparatuses (ammonia concentration apparatuses) 104 and 105, and a culture apparatus 203.
- the raw material gas production apparatus 101, the ammonia synthesis apparatus 102, and the culture apparatus 203 are as described above.
- the manufacturing system 1001 includes gas separation membrane devices 104 and 105 as an ammonia concentrating device.
- the hydrogen gas separation membrane 104 and the nitrogen gas separation membrane 105 can be used in combination.
- the concentrated ammonia gas 6 is obtained.
- the obtained concentrated ammonia gas may be stored in a storage tank (not shown).
- the manufacturing system 1001 shown in FIG. 2 collects unreacted hydrogen and nitrogen separated by the gas separation membrane devices 104 and 105, and recycles the collected gas 5 to the upstream side of the ammonia synthesis device 102. Is provided.
- FIG. 3 shows a production system 1002 including a raw material gas production apparatus 101, an ammonia synthesis apparatus 102, a cooler 106, and a culture apparatus 203.
- the raw material gas production apparatus 101 and the ammonia synthesis apparatus 102 are as described above.
- the ammonia-containing gas 4 obtained by the ammonia synthesizer 102 is cooled by the cooler 106.
- the cooled ammonia-containing gas 6 is supplied to a premixer 204 provided in the culture apparatus 203.
- the culture apparatus 203 includes a premixer 204.
- a medium is circulated between the premixer 204 and the culture tank of the culture apparatus 203.
- ammonia is premixed in the circulating medium. Thereby, the medium mixed with ammonia is supplied to the culture tank of the culture apparatus 203.
- the cooled ammonia-containing gas 6 contains unreacted hydrogen and nitrogen.
- the production system 1002 includes a recycling device that recovers unreacted hydrogen and nitrogen in the premixer 204 and recycles the recovered gas 15 upstream of the ammonia synthesis device 102. Further, the recovered gas 15 contains moisture derived from the culture medium.
- the recycling apparatus includes a dehydrating apparatus 107 that removes moisture in the collected gas 15.
- the manufacturing system 1002 also includes a drying device 108 for further drying the collected gas 15.
- FIG. 4 shows a production system 1003 including a raw material gas production apparatus 101, an ammonia synthesis apparatus 102, a cooler 106, an ammonia water production apparatus 201, an ammonia stripping apparatus 205, and a culture apparatus 203.
- the raw material gas production apparatus 101, the ammonia synthesis apparatus 102, the cooler 106, and the culture apparatus 203 are as described above.
- the ammonia-containing gas 4 obtained by the ammonia synthesizer 102 is cooled by the cooler 106.
- the cooled ammonia-containing gas 6 is supplied to the ammonia water production apparatus 201.
- Water 7 is also supplied to the ammonia water production apparatus 201.
- ammonia water 8 can be produced by dissolving ammonia in the cooled ammonia-containing gas 6 in water 7.
- the method and conditions for dissolution are not particularly limited as long as ammonia water having a desired concentration can be produced, and known methods and conditions may be used.
- the cooled ammonia-containing gas 6 contains unreacted hydrogen and nitrogen.
- the manufacturing system 1003 includes a recycling device that recovers unreacted hydrogen and nitrogen in the ammonia water manufacturing apparatus 201 and recycles the recovered gas 9 upstream of the ammonia synthesis apparatus 102. Further, the recovered gas 9 contains moisture derived from the water 7 used in the ammonia water production apparatus 201.
- the recycling apparatus includes a dehydrating apparatus 107 that removes moisture in the collected gas 9.
- the manufacturing system 1003 also includes a drying device 108 for further drying the collected gas 9.
- the manufactured ammonia water 8 is further used for manufacturing organic compounds or microorganisms.
- the produced ammonia water 8 is supplied to the ammonia stripping device 205 to recover ammonia gas from the ammonia water.
- the ammonia stripping device 205 is not particularly limited as long as ammonia gas can be recovered from the ammonia water, and a known stripping device may be used.
- the organic compound or the microorganism 14 can be produced by culturing a microorganism capable of producing an organic compound in the culture device 203. .
- the water 12 removed by the ammonia stripping device 205 may be merged with the water 7 as shown in FIG.
- the ammonia water 8 produced by the ammonia water production apparatus 201 it is also possible to transport the ammonia water 8 produced by the ammonia water production apparatus 201 to produce organic compounds or microorganisms at geographically distant locations.
- ammonia is supplied to the culture apparatus 203 as a nitrogen source or a pH adjuster, but ammonia is converted into other nitrogen-containing compounds (ammonium salt, urea, nitric acid, nitrate). Thereafter, the nitrogen-containing compound may be supplied to the culture apparatus 203.
- a hydrogen supply apparatus such as a hydrogen cylinder or a hydrogen tank and a nitrogen supply apparatus such as a nitrogen cylinder or a nitrogen tank may be used.
- the concentrated ammonia 6 such as liquid ammonia or concentrated ammonia gas is supplied to the culture apparatus 203 after being converted to ammonia water.
- the present invention also provides a novel method for producing organic compounds or microorganisms.
- the production method of the present invention is characterized in that it does not involve (or minimizes) the transport of liquid ammonia.
- the method for producing an organic compound or microorganism of the present invention comprises: (A) a step of synthesizing an ammonia-containing gas by reacting a raw material gas containing hydrogen and nitrogen in the presence of a supported ruthenium catalyst, and (B) production of an organic compound using the ammonia derived from the obtained ammonia-containing gas.
- the conditions (temperature, pressure, etc.) for synthesizing the supported ruthenium catalyst, raw material gas, ammonia-containing gas, and ammonia-containing gas used in the step (A) are as described in [Production System].
- the organic compound or microorganism produced in the step (B) and the production method thereof are as described in [Production System].
- the advantageous effects described for the manufacturing system of the present invention are similarly applied to the manufacturing method of the present invention.
- step (A) and the step (B) are carried out continuously.
- “continuously carrying out step (A) and step (B)” means carrying out step (B) without transporting the ammonia-containing gas synthesized in step (A) as liquid ammonia. It means to do.
- “Transported as liquid ammonia” means transportation between two geographically separated points by pipeline, aviation, ship, automobile, etc., and includes transportation of organic compounds or microorganisms within the production base. Absent.
- the production method of the present invention may further include a step of producing a source gas containing hydrogen and nitrogen from a hydrogen gas source and air.
- the method for producing the hydrogen gas raw material and the raw material gas is as described in [Production System].
- the production method of the present invention may further include a step of concentrating ammonia in the ammonia-containing gas obtained in step (A).
- the method for concentrating ammonia in the ammonia-containing gas is as described in [Production System].
- the production method of the present invention may further include a step of recovering unreacted hydrogen and nitrogen and recycling the recovered gas to the step (A) (hereinafter referred to as “step (C)”).
- step (C) may include a dehydration process and / or a drying process that removes moisture in the recovered gas.
- the method of dehydration treatment and drying treatment is as described in [Manufacturing System].
- ammonia water is produced using ammonia derived from the ammonia-containing gas obtained in step (A), and the obtained ammonia water is used in step (B). Then, the microorganism having the ability to produce organic compounds is cultured.
- ammonia water is produced using ammonia derived from the ammonia-containing gas obtained in step (A), and ammonia gas is recovered from the obtained ammonia water. Then, the recovered ammonia gas is used in the step (B) to cultivate microorganisms capable of producing organic compounds.
- the production method of the present invention may further include collecting a metabolite from the medium after completion of the culture.
- the method for collecting metabolites is not particularly limited, and metabolites can be collected by combining conventionally known ion exchange resin methods, precipitation methods, and other methods.
- the amount of Cs 2 CO 3 was adjusted so that the element ratio of Cs and Ru was 1: 1.
- the solvent was removed by a rotary evaporator, and evacuation treatment was carried out at room temperature for 12 hours to obtain a Cs—MgO catalyst (powder) carrying 2 wt% of Ru metal particles.
- the resulting catalyst had a BET specific surface area of 12 m 2 / g and a Ru dispersity (%) measured by the CO adsorption method of 25.
- ⁇ Ammonia synthesis reaction> A synthesis reaction was performed in which ammonia gas (NH 3 ) was produced by reacting nitrogen gas (N 2 ) and hydrogen gas (H 2 ).
- 0.1 g of the catalyst obtained by the above method was packed in a glass tube, and a synthesis reaction was performed in a fixed bed flow type reactor.
- the gas flow rates were set to N 2 : 15 mL / min, H 2 : 45 mL / min, and a total of 60 mL / min, and the reaction was performed at a reaction temperature of 340 ° C. and a pressure of atmospheric pressure.
- the gas coming out from the flow reactor was bubbled into a 0.005 M sulfuric acid aqueous solution, the produced ammonia was dissolved in the solution, and the resulting ammonium ions were quantified by ion chromatography.
- the TOF ( ⁇ 10 ⁇ 3 s ⁇ 1 ) was 13.3.
- Ru 3 (CO) 12 purity 99%, manufactured by Aldrich, product number 245011
- a solvent so that the Ru loading is 6 wt% with respect to the Ru—Cs / MgO catalyst, and at room temperature
- the mixture was stirred for 4 hours, and Mg metal was impregnated with Ru metal.
- the mixture was dried at 40 ° C. and 16.0 kPa for 7 hours (1.01 g). 0.81 g of the dried sample was placed in 100 mL of dehydrated ethanol.
- the gas coming out from the flow reactor was passed through water cooled to about 3 ° C., the production rate of ammonia was 3734 ⁇ mol ⁇ 1 h ⁇ 1 , the produced NH 3 was dissolved in water, and the produced NH 3 was dissolved in water, and an aqueous ammonia solution 1 (liquid amount 200 g, NH 4 + amount 1.60 g) was obtained in about 109 hours.
- Example 1 Ammonia gas synthesized in Reference Example 1 is dissolved in water to obtain aqueous ammonia.
- Ammonia gas was recovered from the obtained ammonia water using an ammonia stripping apparatus, and E. E. coli MG1655 is cultured.
- the growth curve shows that the ammonia gas obtained in the present invention can be used for fermentation and culture production.
- Example 2 L-lysine production culture was performed using the aqueous ammonia solution 1 and E. coli produced in Reference Example 2. The following media were used for the culture.
- the Lys-producing bacterium WC196 ⁇ cadA ⁇ ldc / pCABD2 was cultured at 37 ° C. overnight on an LB agar medium supplemented with streptomycin to a final concentration of 80 mg / L. All bacterial cells on a 90 mm diameter plate were scraped from the agar medium after the culture and suspended in 3 mL of physiological saline to prepare a bacterial solution.
- Example 3 In Example 2, the Lys aqueous medium was changed to the following Lys ammonium sulfate medium. Except for the above, L-lysine production culture was carried out in the same manner as in Example 2.
- Lys ammonium sulfate medium Glucose: 20 g / L, (NH 4 ) 2 SO 4 : 12 g / L (using ammonium sulfate solution 1 prepared in Reference Example 3), MgSO 4 .7H 2 O: 1 g / L, KH 2 PO 4 : 1 g / L , Yeast extract: 2 g / L, FeSO 4 ⁇ 7H 2 O: 0.01 g / L, MnSO 4 ⁇ 5H 2 O: 0.008 g / L, adjusted to pH 7.0 using KOH
- Example 2 the aqueous ammonia solution 1 in the Lys-anhydrous medium was changed to a commercially available aqueous ammonia solution (product number 13370-0301, manufactured by Junsei Chemical Co., Ltd.). Except for the above, L-lysine production culture was carried out in the same manner as in Example 2.
- Example 3 the ammonium sulfate solution 1 in the Lys ammonium sulfate medium was changed to a commercially available ammonium sulfate solution (manufactured by Junsei Chemical Co., Ltd., product number 83110-0367). Except for the above, L-lysine production culture was carried out in the same manner as in Example 3.
- Example 4 Using the aqueous ammonia solution Corynebacterium glutamicum prepared in Reference Example 2, L-glutamic acid production culture was performed. The following media were used for the culture.
- CM-Ace agar medium Glucose: 2.5 g / L, fructose: 2.5 g / L, sodium gluconate: 4 g / L, sodium succinate ⁇ 6H 2 O: 2 g / L, peptone: 10 g / L, Yeast Extract: 10 g / L, KH 2 PO 4 : 1 g / L, MgSO 4 ⁇ 7H 2 O: 0.4 g / L, FeSO 4 ⁇ 7H 2 O: 0.01 g / L, MnSO 4 ⁇ 5H 2 O: 0.01 g / L, Urea: 4 g / L, bean filtrate (soybean hydrolyzate): 1.2 g / L (TN), biotin: 1 mg / L, vitamin
- a Glu-producing bacterium 2256 ⁇ ldhA ⁇ sucA yggB * of Corynebacterium glutamicum was cultured overnight at 31.5 ° C. on a CM-Ace agar medium.
- a 1/24 plate of cells was scraped from the cultured agar medium, and 5 ml of Glu Aqueous medium supplemented with calcium carbonate that had been preliminarily sterilized by dry heat to a final concentration of 30 g / L.
- the test tube was inoculated and cultured with shaking at 31.5 ° C. and 120 rpm for 24 hours.
- Example 5 In Example 4, the Glu ammonium sulfate culture medium was changed to the following Glu ammonium sulfate culture medium. Except for the above, L-glutamic acid production culture was carried out in the same manner as in Example 4.
- [Glu ammonium sulfate medium] Glucose: 40 g / L, (NH 4 ) 2 SO 4 : 15 g / L (using ammonium sulfate solution 1 prepared in Reference Example 3), KH 2 PO 4 : 1 g / L, MgSO 4 .7H 2 O: 0.4 g / L, FeSO 4 ⁇ 7H 2 O: 0.01 g / L, MnSO 4 ⁇ 5H 2 O: 0.01 g / L, Vitamin B1: 200 ⁇ g / L, Biotin: 300 ⁇ g / L, Bean filtrate: 0.48 g / L Adjust to pH 8.0 using L (TN), KOH
- Example 4 the aqueous ammonia solution 1 in the Glu-an aqueous medium was changed to a commercially available aqueous ammonia solution (product number 13370-0301, manufactured by Junsei Chemical Co., Ltd.). Except for the above, L-glutamic acid production culture was carried out in the same manner as in Example 4.
- Example 5 the ammonium sulfate solution 1 in the Glu ammonium sulfate medium was changed to a commercially available ammonium sulfate solution (manufactured by Junsei Chemical Co., Ltd., product number 83110-0367). Except for the above, L-glutamic acid production culture was carried out in the same manner as in Example 5.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Sustainable Development (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Clinical Laboratory Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
[1] 担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成するアンモニア合成装置と、
アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する培養装置と、
を含む、有機化合物又は微生物の製造システム。
[2] アンモニア合成装置において、530℃以下の反応温度、30MPa以下の反応圧力の条件にて原料ガスを反応させる、[1]に記載の製造システム。
[3] アンモニア合成装置で得られたアンモニア含有ガス中のアンモニアを濃縮するアンモニア濃縮装置をさらに含む、[1]又は[2]に記載の製造システム。
[4] アンモニア合成装置の下流側において、未反応の水素と窒素を回収し、回収したガスをアンモニア合成装置の上流側にリサイクルするリサイクル装置をさらに含む、[1]~[3]のいずれかに記載の製造システム。
[5] リサイクル装置が、回収したガス中の水分を除去する脱水装置及び/又は乾燥装置を含む、[4]に記載の製造システム。
[6] アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水を用いて有機化合物の生産能を有する微生物を培養する、[1]~[5]のいずれかに記載の製造システム。
[7] アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水からアンモニアガスを回収し、回収されたアンモニアガスを用いて有機化合物の生産能を有する微生物を培養する、[1]~[5]のいずれかに記載の製造システム。
[8] 培養装置において、窒素源又はpH調整剤としてアンモニアを使用する、[1]~[7]のいずれかに記載の製造システム。
[9] 微生物が、アミノ酸、有機酸、多糖類、タンパク質、抗生物質、及びアルコールからなる群から選択される有機化合物の生産能を有する、[1]~[8]のいずれかに記載の製造システム。
[10] 微生物が、細菌又は真菌である、[1]~[9]のいずれかに記載の製造システム。
[11] (A)担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成する工程、及び
(B)得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する工程
を含む、有機化合物又は微生物の製造方法。
[12] 工程(A)と工程(B)を連続的に実施する、[11]に記載の方法。
[13] 工程(A)において、530℃以下の反応温度、30MPa以下の反応圧力の条件にて原料ガスを反応させる、[11]又は[12]に記載の方法。
[14] 工程(A)で得られたアンモニア含有ガス中のアンモニアを濃縮する工程をさらに含む、[11]~[13]のいずれかに記載の方法。
[15] 工程(A)の後に、未反応の水素と窒素を回収し、回収したガスを工程(A)にリサイクルする工程をさらに含む、[11]~[14]のいずれかに記載の方法。
[16] リサイクルする工程において、回収したガス中の水分を除去する脱水処理及び/又は乾燥処理を実施する、[15]に記載の方法。
[17] 工程(A)で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水を工程(B)において使用して有機化合物の生産能を有する微生物を培養する、[11]~[16]のいずれかに記載の方法。
[18] 工程(A)で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水からアンモニアガスを回収し、回収されたアンモニアガスを工程(B)において使用して有機化合物の生産能を有する微生物を培養する、[11]~[16]のいずれかに記載の方法。
[19] 工程(B)において、窒素源又はpH調整剤としてアンモニアを使用する、[11]~[18]のいずれかに記載の方法。
[20] 微生物が、アミノ酸、有機酸、多糖類、タンパク質、抗生物質、及びアルコールからなる群から選択される有機化合物の生産能を有する、[11]~[19]のいずれかに記載の方法。
[21] 微生物が、細菌又は真菌である、[11]~[20]のいずれかに記載の方法。
本発明は、有機化合物又は微生物の新規な製造システムを提供する。
担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成するアンモニア合成装置と、
アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する培養装置と、
を含む。
本発明の製造システムにおいて、アンモニア合成装置は、担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成する。
本発明の製造システムにおいて、培養装置は、アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する。
本発明はまた、有機化合物又は微生物の新規な製造方法を提供する。本発明の製造方法では、液体アンモニアの輸送を伴わない(あるいは最小限に抑える)ことを特徴とする。
(A)担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成する工程、及び
(B)得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する工程
を含む。
<Ruを担持したCs-MgOの合成>
MgO(宇部マテリアルズ(株)社製、製品番号UC95)(1g)を、500℃で5時間真空排気加熱し、Ar雰囲気下でRu3(CO)12を溶解させたテトラヒドロフラン溶液中に浸漬した。3時間攪拌後、ロータリーエバポレーターにより溶媒を除去し、350℃で2時間真空排気加熱をした。これにより2wt%のRu金属粒子を担持したMgO触媒が得られた。さらに得られた触媒をAr雰囲気下でCs2CO3を溶解させたエタノール溶液中に浸漬した。このとき、CsとRuの元素比が1:1となるようにCs2CO3の量を調節した。3時間攪拌後、ロータリーエバポレーターにより溶媒を除去し、室温で12時間真空排気処理を行うことで2wt%のRu金属粒子を担持したCs-MgO触媒(powder)が得られた。得られた触媒のBET比表面積は12m2/g、CO吸着法で測定したRu分散度(%)は25であった。
窒素ガス(N2)と水素ガス(H2)を反応させてアンモニアガス(NH3)を生成する合成反応を行った。上記の方法で得られた触媒0.1gをガラス管に詰め、固定床流通式反応装置で合成反応を行った。ガスの流量は、N2:15mL/min、H2:45mL/min、計60mL/minに設定し、反応温度:340℃、圧力:大気圧で反応を行った。流通系の反応器から出てきたガスを0.005M硫酸水溶液中にバブリングさせ、生成したアンモニアを溶液中に溶解させ、生じたアンモニウムイオンをイオンクロマトグラフにより定量した。
<Ru-Cs/MgO触媒(RuとともにCsをMgOに担持した触媒)の合成>
MgO(宇部マテリアルズ(株)社製、製品番号UC95)粉末を石英ガラス容器に入れて、500℃で6時間真空排気した脱水処理した。脱水したMgO 1.00gを超脱水THF溶媒(和光純薬工業(株)社製、製品番号207-17765)60mL中に入れた。Ru担持量が、Ru-Cs/MgO触媒に対して6wt%となるように溶媒中にRu3(CO)12(純度99%、Aldrich社製、製品番号245011)0.02gを入れ、室温で4時間撹拌し、MgOにRu金属を含浸担持した。エバポレーターを使用し、40℃、16.0kPaにて7時間かけて乾固させた(1.01g)。乾固させた試料0.81gを脱水エタノール100mL中に入れた。RuとCsのモル比が1:1となるようにCs2CO3(関東化学(株)社製、製品番号07184-33)0.078gを入れ、室温で4時間撹拌し、Ru/MgOにCs金属を含浸担持した。エバポレーターを使用し、室温、9.0kPaにて7時間乾固した。6wt%Ru-Cs/MgO触媒0.087gを得た。
窒素ガス(N2)と水素ガス(H2)を反応させてアンモニアガス(NH3)を生成する反応を行った。得られた触媒0.2gを耐圧管に詰め、固定床流通式反応装置で反応を行った。ガスの流量は、N2:15mL/min、H2:45mL/min、計60mL/minに設定し、圧力:0.9MPa、反応温度400℃で反応を行った。流通系の反応器から出てきたガスを約3℃に冷却した水中に通気させ、アンモニアの生成速度は3734μmolg-1h-1であり、生成したNH3を水中に溶解し、生成したNH3を水中に溶解させ、約109時間でアンモニア水溶液1(液量200g、NH4 +量1.60g)を得た。
<硫酸アンモニウム溶液の製造>
参考例2のアンモニア水の製造において、反応温度400℃で、反応圧力を0.9MPaから0.1MPaに変え、さらに流通系の反応器から出てきたガスを約3℃に冷却した水に通気させることを、流通系の反応器から出てきたガスを室温下で0.220M硫酸水溶液に通気させることに変えた。以上の事項以外は参考例2と同様にして硫酸アンモニウムの製造を行った。アンモニアの生成速度は、3531μmolh-1g-1であり、約56時間で硫酸アンモニウム溶液1(液量100g、NH4 +量0.81g)を得た。
参考例1により合成されたアンモニアガスを水に溶解し、アンモニア水を得る。
生育曲線より、本発明で得られたアンモニアガスは、発酵・培養生産に用いることが可能であることが示される。
参考例2で製造したアンモニア水溶液1、E.coliを用いてL-リジン生産培養をした。培養には以下の培地を用いた。
トリプトン:10g/L、酵母エキス:5g/L、NaCl:10g/L、寒天:15g/L
〔Lys安水培地〕
グルコース:20g/L、NH3:3.09g/L(参考例2で製造したアンモニア水溶液1を使用)、MgSO4・7H2O:1g/L、KH2PO4:1g/L、酵母エキス:2g/L、FeSO4・7H2O:0.01g/L、MnSO4・5H2O:0.008g/L、H2SO4を用いてpH7.0に調整
実施例2において、Lys安水培地を以下のLys硫安培地に変えた。以上の事項以外は実施例2と同様にしてL-リジンの生産培養を行った。
〔Lys硫安培地〕
グルコース:20g/L、(NH4)2SO4:12g/L(参考例3で製造した硫酸アンモニウム溶液1を使用)、MgSO4・7H2O:1g/L、KH2PO4:1g/L、酵母エキス:2g/L、FeSO4・7H2O:0.01g/L、MnSO4・5H2O:0.008g/L、KOHを用いてpH7.0に調整
実施例2において、Lys安水培地におけるアンモニア水溶液1を市販品のアンモニア水溶液(純正化学(株)社製、製品番号13370-0301)に変えた。以上の事項以外は実施例2と同様にしてL-リジンの生産培養を行った。
実施例3において、Lys硫安培地における硫酸アンモニウム溶液1を市販品の硫酸アンモニウム溶液(純正化学(株)社製、製品番号83110-0367)に変えた。以上の事項以外は実施例3と同様にしてL-リジンの生産培養を行った。
参考例2で製造したアンモニア水溶液、Corynebacterium glutamicumを用いてL-グルタミン酸の生産培養を行った。培養には以下の培地を用いた。
〔CM-Ace寒天培地〕
グルコース:2.5g/L、フルクトース:2.5g/L、グルコン酸ナトリウム:4g/L、コハク酸ナトリウム・6H2O:2g/L、ペプトン:10g/L、Yeast Extract:10g/L、KH2PO4:1g/L、MgSO4・7H2O:0.4g/L、FeSO4・7H2O:0.01g/L、MnSO4・5H2O:0.01g/L、Urea:4g/L、豆ろ液(大豆加水分解物):1.2g/L(T-N)、ビオチン:1mg/L、ビタミンB1:5mg/L、KOHを用いてpH7.5に調整
〔Glu安水培地〕
グルコース:40g/L、NH3(参考例2で製造したアンモニア水溶液1を使用)3.86g/L、KH2PO4:1g/L、MgSO4・7H2O:0.4g/L、FeSO4・7H2O:0.01g/L、MnSO4・5H2O:0.01g/L、ビタミンB1:200μg/L、ビオチン:300μg/L、豆ろ液:0.48g/L(T-N)、K2SO4:19.78g/L、H2SO4を用いてpH8.0に調整
実施例4において、Glu安水培地を以下のGlu硫安培地に変えた。以上の事項以外は実施例4と同様にしてL-グルタミン酸の生産培養を行った。
〔Glu硫安培地〕
グルコース:40g/L、(NH4)2SO4:15g/L(参考例3で製造した硫酸アンモニウム溶液1を使用)、KH2PO4:1g/L、MgSO4・7H2O:0.4g/L、FeSO4・7H2O:0.01g/L、MnSO4・5H2O:0.01g/L、ビタミンB1:200μg/L、ビオチン:300μg/L、豆ろ液:0.48g/L(T-N)、KOHを用いてpH8.0に調整
実施例4において、Glu安水培地におけるアンモニア水溶液1を市販品のアンモニア水溶液(純正化学(株)社製、製品番号13370-0301)に変えた。以上の事項以外は実施例4と同様にしてL-グルタミン酸の生産培養を行った。
実施例5において、Glu硫安培地における硫酸アンモニウム溶液1を市販品の硫酸アンモニウム溶液(純正化学(株)社製、製品番号83110-0367)に変えた。以上の事項以外は実施例5と同様にしてL-グルタミン酸の生産培養を行った。
2 空気
3 水素と窒素を含む原料ガス
4 アンモニア含有ガス
5、9、15 回収したガス
6 濃縮アンモニア
7 水
8 アンモニア水
12 アンモニアストリッピング装置で除去した水
13 空気
14 有機化合物又は微生物
101 水素/窒素製造装置
102 アンモニア合成装置
103 アンモニア濃縮装置
104、105 ガス分離膜
106 冷却器
107 脱水装置
108 乾燥装置
201 アンモニア水製造装置
203 培養装置
204 予混合器
205 アンモニアストリッピング装置
1000、1001、1002、1003 有機化合物又は微生物の製造システム
Claims (21)
- 担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成するアンモニア合成装置と、
アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する培養装置と、
を含む、有機化合物又は微生物の製造システム。 - アンモニア合成装置において、530℃以下の反応温度、30MPa以下の反応圧力の条件にて原料ガスを反応させる、請求項1に記載の製造システム。
- アンモニア合成装置で得られたアンモニア含有ガス中のアンモニアを濃縮するアンモニア濃縮装置をさらに含む、請求項1又は2に記載の製造システム。
- アンモニア合成装置の下流側において、未反応の水素と窒素を回収し、回収したガスをアンモニア合成装置の上流側にリサイクルするリサイクル装置をさらに含む、請求項1~3のいずれか1項に記載の製造システム。
- リサイクル装置が、回収したガス中の水分を除去する脱水装置及び/又は乾燥装置を含む、請求項4に記載の製造システム。
- アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水を用いて有機化合物の生産能を有する微生物を培養する、請求項1~5のいずれか1項に記載の製造システム。
- アンモニア合成装置で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水からアンモニアガスを回収し、回収されたアンモニアガスを用いて有機化合物の生産能を有する微生物を培養する、請求項1~5のいずれか1項に記載の製造システム。
- 培養装置において、窒素源又はpH調整剤としてアンモニアを使用する、請求項1~7のいずれか1項に記載の製造システム。
- 微生物が、アミノ酸、有機酸、多糖類、タンパク質、抗生物質、及びアルコールからなる群から選択される有機化合物の生産能を有する、請求項1~8のいずれか1項に記載の製造システム。
- 微生物が、細菌又は真菌である、請求項1~9のいずれか1項に記載の製造システム。
- (A)担持ルテニウム触媒の存在下、水素と窒素を含む原料ガスを反応させてアンモニア含有ガスを合成する工程、及び
(B)得られたアンモニア含有ガス由来のアンモニアを使用して有機化合物の生産能を有する微生物を培養する工程
を含む、有機化合物又は微生物の製造方法。 - 工程(A)と工程(B)を連続的に実施する、請求項11に記載の方法。
- 工程(A)において、530℃以下の反応温度、30MPa以下の反応圧力の条件にて原料ガスを反応させる、請求項11又は12に記載の方法。
- 工程(A)で得られたアンモニア含有ガス中のアンモニアを濃縮する工程をさらに含む、請求項11~13のいずれか1項に記載の方法。
- 工程(A)の後に、未反応の水素と窒素を回収し、回収したガスを工程(A)にリサイクルする工程をさらに含む、請求項11~14のいずれか1項に記載の方法。
- リサイクルする工程において、回収したガス中の水分を除去する脱水処理及び/又は乾燥処理を実施する、請求項15に記載の方法。
- 工程(A)で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水を工程(B)において使用して有機化合物の生産能を有する微生物を培養する、請求項11~16のいずれか1項に記載の方法。
- 工程(A)で得られたアンモニア含有ガス由来のアンモニアを使用してアンモニア水を製造し、得られたアンモニア水からアンモニアガスを回収し、回収されたアンモニアガスを工程(B)において使用して有機化合物の生産能を有する微生物を培養する、請求項11~16のいずれか1項に記載の方法。
- 工程(B)において、窒素源又はpH調整剤としてアンモニアを使用する、請求項11~18のいずれか1項に記載の方法。
- 微生物が、アミノ酸、有機酸、多糖類、タンパク質、抗生物質、及びアルコールからなる群から選択される有機化合物の生産能を有する、請求項11~19のいずれか1項に記載の方法。
- 微生物が、細菌又は真菌である、請求項11~20のいずれか1項に記載の方法。
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112017017426-0A BR112017017426B1 (pt) | 2015-02-17 | 2016-02-17 | Sistema e método de produção para um composto orgânico |
CN201680010598.XA CN107250342A (zh) | 2015-02-17 | 2016-02-17 | 有机化合物或微生物的制造系统及制造方法 |
JP2017500721A JP6798976B2 (ja) | 2015-02-17 | 2016-02-17 | 有機化合物又は微生物の製造システム及び製造方法 |
EP16752520.3A EP3260526A4 (en) | 2015-02-17 | 2016-02-17 | Production system and production method for organic compounds or microbes |
US15/675,113 US10808267B2 (en) | 2015-02-17 | 2017-08-11 | Production system and method of production for organic compound or microorganism |
US17/019,666 US20200407762A1 (en) | 2015-02-17 | 2020-09-14 | Production System and Method of Production for Organic Compound or Microorganism |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015028959 | 2015-02-17 | ||
JP2015-028959 | 2015-02-17 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/675,113 Continuation US10808267B2 (en) | 2015-02-17 | 2017-08-11 | Production system and method of production for organic compound or microorganism |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016133134A1 true WO2016133134A1 (ja) | 2016-08-25 |
Family
ID=56692303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2016/054611 WO2016133134A1 (ja) | 2015-02-17 | 2016-02-17 | 有機化合物又は微生物の製造システム及び製造方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US10808267B2 (ja) |
EP (1) | EP3260526A4 (ja) |
JP (2) | JP6798976B2 (ja) |
CN (1) | CN107250342A (ja) |
BR (1) | BR112017017426B1 (ja) |
PE (1) | PE20171663A1 (ja) |
WO (1) | WO2016133134A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110004081A (zh) * | 2019-03-25 | 2019-07-12 | 江西省科学院微生物研究所 | 一种能拆分(+/-)γ-内酰胺得到(+)γ-内酰胺的菠萝泛菌及其应用 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20180153A1 (es) * | 2015-02-17 | 2018-01-18 | Ajinomoto Kk | Sistema de produccion y metodo de produccion para producto seleccionado entre producto que contiene nitrogeno y producto fermentado y cultivado |
CN108247553B (zh) * | 2017-12-30 | 2020-11-17 | 义乌市安航科技有限公司 | 一种耐磨人造油石的制备方法 |
WO2021102248A1 (en) * | 2019-11-20 | 2021-05-27 | Oakbio, Inc. | Bioreactors with integrated catalytic nitrogen fixation |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56124496A (en) * | 1979-09-29 | 1981-09-30 | Ebara Infilco Co Ltd | Treatment of waste water containing nitrogen in ammonia form and dithionates |
JPS61192295A (ja) * | 1985-02-21 | 1986-08-26 | Mitsubishi Chem Ind Ltd | L−フエニルアラニンの製造法 |
JP2002052341A (ja) * | 2000-07-06 | 2002-02-19 | Haldor Topsoe As | 接触的アンモニア製造方法−アンモニア合成触媒の製造と回収法 |
JP2003020221A (ja) * | 2001-07-05 | 2003-01-24 | Nkk Corp | アンモニア水製造装置 |
WO2006038695A1 (ja) * | 2004-10-07 | 2006-04-13 | Ajinomoto Co., Inc. | 塩基性物質の製造法 |
JP2008247654A (ja) * | 2007-03-29 | 2008-10-16 | Hiroshima Univ | アンモニアの分離方法、製造方法、及び気体分離膜 |
JP2010017082A (ja) * | 2006-10-10 | 2010-01-28 | Ajinomoto Co Inc | L−アミノ酸の製造法 |
JP2011521134A (ja) * | 2008-05-22 | 2011-07-21 | ニトラ−ジェン エルエルシー | 硝酸イオンのオンサイト製造の方法および装置 |
JP2011246311A (ja) * | 2010-05-28 | 2011-12-08 | Nippon Shokubai Co Ltd | アンモニア合成方法 |
WO2012077658A1 (ja) * | 2010-12-07 | 2012-06-14 | 国立大学法人東京工業大学 | アンモニア合成触媒及びアンモニア合成方法 |
JP2013111563A (ja) * | 2011-11-30 | 2013-06-10 | Sumitomo Chemical Co Ltd | 組成物及び該組成物を用いたアンモニア製造方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4819952B1 (ja) * | 1968-03-30 | 1973-06-18 | ||
JPS515073B1 (ja) * | 1969-07-08 | 1976-02-17 | ||
JPS4937278B1 (ja) * | 1969-07-08 | 1974-10-07 | ||
CA965766A (en) * | 1970-06-22 | 1975-04-08 | Akio Furuta | Ammonia synthesis catalyst and process |
JPS4835086A (ja) * | 1971-09-06 | 1973-05-23 | ||
JPS49126882A (ja) * | 1973-04-19 | 1974-12-04 | ||
US3897303A (en) | 1974-01-23 | 1975-07-29 | Phillips Petroleum Co | Integrated process of ammonia production and biosynthesis |
US4242458A (en) * | 1978-10-25 | 1980-12-30 | Texaco Development Corporation | Biosynthesis of protein by fermentation of methanol obtained from the gasification of coal or residual oil |
JPS6046918A (ja) * | 1983-08-25 | 1985-03-14 | Toyo Eng Corp | アンモニアの合成法 |
DE3679090D1 (de) * | 1985-03-08 | 1991-06-13 | Ici Plc | Synthesegas. |
KR100379887B1 (ko) | 1995-06-05 | 2003-06-12 | 스타텍 벤처스, 인코포레이티드 | 반도체제조용암모니아의온-사이트(on-site)정제 |
FR2750998B1 (fr) * | 1996-07-09 | 1998-09-18 | Ceca Sa | Procede de preparation de k-carraghenase |
JP3924669B2 (ja) * | 1998-05-27 | 2007-06-06 | 日立造船株式会社 | アンモニア水溶液の製造方法 |
US6955797B1 (en) * | 1998-10-30 | 2005-10-18 | Haldor Topsoe A/S | Process for the preparation of ammonia |
KR100815041B1 (ko) * | 1999-08-02 | 2008-03-18 | 아처 다니엘 미드랜드 캄파니 | 아미노산 생산의 대사 공학 |
WO2001009306A2 (en) * | 1999-08-02 | 2001-02-08 | Archer-Daniels-Midland Company | Mutant bacterial strains l-lysine production |
JP2001069999A (ja) * | 1999-09-01 | 2001-03-21 | Nikken Chem Co Ltd | エリスリトールの製造方法 |
JP2002012420A (ja) * | 2000-06-22 | 2002-01-15 | Nkk Design & Engineering Corp | アンモニアの分離方法 |
JP4117417B2 (ja) * | 2002-03-15 | 2008-07-16 | 日立造船株式会社 | アンモニアの製造方法、及びその装置 |
US7507561B2 (en) * | 2004-05-20 | 2009-03-24 | Reliance Life Sciences Pvt. Ltd. | Process for the production of polylactic acid (PLA) from renewable feedstocks |
JP4575806B2 (ja) * | 2005-02-18 | 2010-11-04 | 三井化学株式会社 | オンサイト型ガス製造装置およびガス製造販売システム |
WO2007032265A1 (ja) * | 2005-09-15 | 2007-03-22 | New Century Fermentation Research Ltd. | アルコール生産細菌の連続培養装置及びその方法 |
CN101186934A (zh) * | 2007-11-22 | 2008-05-28 | 上海氯碱化工股份有限公司 | 基于根霉菌的l-乳酸铵的连续生产方法 |
US20130039833A1 (en) * | 2009-07-15 | 2013-02-14 | LiveFuels, Inc. | Systems and methods for producing ammonia fertilizer |
CN102815721A (zh) * | 2011-06-08 | 2012-12-12 | 福州开发区科盛催化材料有限公司 | 一种低压氨合成的方法 |
US20140322124A1 (en) * | 2013-04-26 | 2014-10-30 | Japan Pionics Co., Ltd. | Method of processing discharge gas discharged from production process of gallium nitride compound semiconductor |
-
2016
- 2016-02-17 EP EP16752520.3A patent/EP3260526A4/en active Pending
- 2016-02-17 BR BR112017017426-0A patent/BR112017017426B1/pt active IP Right Grant
- 2016-02-17 WO PCT/JP2016/054611 patent/WO2016133134A1/ja active Application Filing
- 2016-02-17 JP JP2017500721A patent/JP6798976B2/ja active Active
- 2016-02-17 CN CN201680010598.XA patent/CN107250342A/zh active Pending
- 2016-02-17 PE PE2017001406A patent/PE20171663A1/es unknown
-
2017
- 2017-08-11 US US15/675,113 patent/US10808267B2/en active Active
-
2020
- 2020-09-14 US US17/019,666 patent/US20200407762A1/en active Pending
- 2020-11-19 JP JP2020192494A patent/JP7496993B2/ja active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56124496A (en) * | 1979-09-29 | 1981-09-30 | Ebara Infilco Co Ltd | Treatment of waste water containing nitrogen in ammonia form and dithionates |
JPS61192295A (ja) * | 1985-02-21 | 1986-08-26 | Mitsubishi Chem Ind Ltd | L−フエニルアラニンの製造法 |
JP2002052341A (ja) * | 2000-07-06 | 2002-02-19 | Haldor Topsoe As | 接触的アンモニア製造方法−アンモニア合成触媒の製造と回収法 |
JP2003020221A (ja) * | 2001-07-05 | 2003-01-24 | Nkk Corp | アンモニア水製造装置 |
WO2006038695A1 (ja) * | 2004-10-07 | 2006-04-13 | Ajinomoto Co., Inc. | 塩基性物質の製造法 |
JP2010017082A (ja) * | 2006-10-10 | 2010-01-28 | Ajinomoto Co Inc | L−アミノ酸の製造法 |
JP2008247654A (ja) * | 2007-03-29 | 2008-10-16 | Hiroshima Univ | アンモニアの分離方法、製造方法、及び気体分離膜 |
JP2011521134A (ja) * | 2008-05-22 | 2011-07-21 | ニトラ−ジェン エルエルシー | 硝酸イオンのオンサイト製造の方法および装置 |
JP2011246311A (ja) * | 2010-05-28 | 2011-12-08 | Nippon Shokubai Co Ltd | アンモニア合成方法 |
WO2012077658A1 (ja) * | 2010-12-07 | 2012-06-14 | 国立大学法人東京工業大学 | アンモニア合成触媒及びアンモニア合成方法 |
JP2013111563A (ja) * | 2011-11-30 | 2013-06-10 | Sumitomo Chemical Co Ltd | 組成物及び該組成物を用いたアンモニア製造方法 |
Non-Patent Citations (3)
Title |
---|
HIROTA, R. ET AL.: "Molecular Biology of Ammonia-Oxidizing Bacteria", J. ENVIRONMENTAL BIOTECHNOLOGY, vol. 2, no. 2, 2002, pages 135 - 143, XP009505912 * |
MASAAKI KITANO ET AL.: "Ko-kassei Ammonia Gosei Shokubai no Kaihatsu", KAGAKU KEIZAI, vol. 60, no. 2, 2013, pages 73 - 77, XP009505914 * |
See also references of EP3260526A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110004081A (zh) * | 2019-03-25 | 2019-07-12 | 江西省科学院微生物研究所 | 一种能拆分(+/-)γ-内酰胺得到(+)γ-内酰胺的菠萝泛菌及其应用 |
CN110004081B (zh) * | 2019-03-25 | 2022-09-13 | 江西省科学院微生物研究所 | 一种能拆分(+/-)γ-内酰胺得到(+)γ-内酰胺的菠萝泛菌及其应用 |
Also Published As
Publication number | Publication date |
---|---|
EP3260526A4 (en) | 2018-11-21 |
US10808267B2 (en) | 2020-10-20 |
BR112017017426A2 (ja) | 2018-04-03 |
JPWO2016133134A1 (ja) | 2018-01-11 |
JP7496993B2 (ja) | 2024-06-10 |
PE20171663A1 (es) | 2017-11-15 |
JP6798976B2 (ja) | 2020-12-09 |
BR112017017426B1 (pt) | 2022-04-26 |
US20200407762A1 (en) | 2020-12-31 |
CN107250342A (zh) | 2017-10-13 |
EP3260526A1 (en) | 2017-12-27 |
US20170342450A1 (en) | 2017-11-30 |
JP2021027837A (ja) | 2021-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7496993B2 (ja) | 有機化合物又は微生物の製造システム及び製造方法 | |
US10941427B2 (en) | Production system and method of production for product selected from nitrogen-containing product and fermented and cultured product | |
EP2217696B1 (en) | Novel bacteria and methods of use thereof | |
ES2689456T3 (es) | Método de mantener la viabilidad de cultivos | |
NZ546496A (en) | Gas treatment process | |
CA2893431C (en) | Fermentative production of a hydrocarbon | |
JPWO2008143015A1 (ja) | コハク酸およびコハク酸アンモニウム溶液の製造方法 | |
CN109890969B (zh) | 使用二氧化碳矿化方法与硫氧化微生物的代谢的结合的二氧化碳转化方法 | |
Li et al. | A novel strategy of feeding nitrate for cost-effective production of poly-γ-glutamic acid from crude glycerol by Bacillus licheniformis WX-02 | |
Choudhury et al. | Lactic acid fermentation in cell-recycle membrane bioreactor | |
US20120309075A1 (en) | Novel Bacteria and Methods of Use thereof | |
JPH06277081A (ja) | メタン生成細菌による5−アミノレブリン酸の生産方法 | |
JP2013013353A (ja) | 1,3−プロパンジオールの製造方法 | |
TW200914620A (en) | Method for producing malic acid | |
AU2008321615B2 (en) | Novel bacteria and methods of use thereof | |
CN118006695A (zh) | 一种树脂原位分离有机酸耦合发酵的方法 | |
CN105821013A (zh) | 羰基还原酶及其在制备手性n-保护-羟基氮杂环中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16752520 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2017500721 Country of ref document: JP Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2016752520 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 001406-2017 Country of ref document: PE |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112017017426 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112017017426 Country of ref document: BR Kind code of ref document: A2 Effective date: 20170814 |